{
  "abstract": "BackgroundAccelerated bone loss is often observed in postmenopausal women with breast cancer receiving long-term aromatase inhibitor (AI) therapy; particularly, there is a growing need for targeted nutritional interventions.MethodsThis multi-database bibliometric study evaluated 25 years of literature from 2000 to 2025 retrieved from the Web of Science Core Collection and Scopus. Following PRISMA guidelines, 768 publications were assessed using R-based analytical workflows to examine output trends, collaboration networks, thematic evolution, and citation impact.ResultsAnnual scientific production expanded between 2005 and reached a peak in 2011, followed by a stable plateau of annual output through 2025. With strong institutional networks in North America and Europe, the United States was the productivity leader. A conceptual transition from isolated antiresorptive medications (bisphosphonates, denosumab) to an integrative bone microenvironment preservation strategy was suggested by keyword and thematic analyses. Keyword patterns suggested that Vitamin D and calcium are frequently integrated as universal baseline co-therapies, and topics including obesity, treatment-associated arthralgia, and survivorship exhibited high citation impact.ConclusionStudies on AI-associated bone loss (AIBL) have moved beyond routine BMD measurement to the structured co-management of micronutrients and metabolism, which may in turn guide future breast cancer survivorship research.",
  "abstract_shown": true,
  "affiliations": [
    "epartment of Breast and Thyroid Surgery, The First People's Hospital of Yunnan Province, Kunming, China"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 4,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Zhenfan Huang"
    },
    {
      "affs": [
        0
      ],
      "name": "Yuyu Zhang"
    },
    {
      "affs": [
        0
      ],
      "name": "Qiongyu Wu"
    },
    {
      "affs": [
        0
      ],
      "name": "Shaoda Meng"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/43b87swtvh49k.bib",
  "cited_by": 0,
  "doi": "10.3389/fnut.2026.1969024",
  "fulltext_url": "https://www.frontiersin.org/articles/10.3389/fnut.2026.1969024/full",
  "id": "43b87swtvh49k",
  "issns": [
    "2296-861X"
  ],
  "landing_url": "https://doi.org/10.3389/fnut.2026.1969024",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "TX341-641"
    ],
    [
      "openalex",
      "2732|Bone health and osteoporosis research"
    ]
  ],
  "openalex": "W7223708277",
  "pdf_url": "https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1969024/pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-10-26",
  "publisher": "Frontiers Media S.A.",
  "ris": "https://research.draconitic.com/paper/43b87swtvh49k.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T13:47:23Z",
      "native_id": "d698aaefdd914267988e2d8a4214b862",
      "source": "doaj",
      "url": "https://doi.org/10.3389/fnut.2026.1969024"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2732|Bone health and osteoporosis research",
      "subfield": "surgery"
    }
  ],
  "title": "Translational trends and specific nutritional interventions for aromatase inhibitor induced bone loss based on a 25 year multi database bibliometric and thematic evolution analysis from 2000 to 2025",
  "title_text": "Translational trends and specific nutritional interventions for aromatase inhibitor induced bone loss based on a 25 year multi database bibliometric and thematic evolution analysis from 2000 to 2025",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T13:47:23Z",
  "url": "https://research.draconitic.com/paper/43b87swtvh49k",
  "venue": "Frontiers in Nutrition",
  "versions": []
}